Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial

AIM: To compare the cardiovascular (CV) safety of linagliptin with glimepiride in older and younger participants in the CAROLINA trial in both prespecified and post hoc analyses. MATERIALS AND METHODS: People aged 40 to 85 years with relatively early type 2 diabetes, inadequate glycaemic control and...

Descripción completa

Detalles Bibliográficos
Autores principales: Espeland, Mark A., Pratley, Richard E., Rosenstock, Julio, Kadowaki, Takashi, Seino, Yutaka, Zinman, Bernard, Marx, Nikolaus, McGuire, Darren K., Andersen, Knut Robert, Mattheus, Michaela, Keller, Annett, Weber, Maria, Johansen, Odd Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839453/
https://www.ncbi.nlm.nih.gov/pubmed/33185002
http://dx.doi.org/10.1111/dom.14254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839453/
https://www.ncbi.nlm.nih.gov/pubmed/33185002
http://dx.doi.org/10.1111/dom.14254

Ejemplares similares